HEADER IMMUNE SYSTEM 13-SEP-10 2XRA TITLE CRYSTAL STRUCTURE OF THE HK20 FAB IN COMPLEX WITH A GP41 MIMETIC 5- TITLE 2 HELIX COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSMEMBRANE PROTEIN GP41; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: 5-HELIX INNER-CORE MIMETIC COMPRISED OF REPEATS OF RESIDUES COMPND 5 543-582 AND 625-662; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: SEQUENCE DERIVED FROM UNIPROT AC P04578 WHERE THREE COMPND 8 REGIONS EACH EQUIVALENT TO AA 543-582 ARE INTERSPERSED BY TWO COMPND 9 DIFFERENT REGIONS (EACH EQUIVALENT TO AA 625-662). LINKERS GGSGG AND COMPND 10 GSSGG JOIN THE REGIONS AND ALTERNATE STARTING WITH GGSGG. A; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: HK20, HUMAN MONOCLONAL ANTIBODY HEAVY CHAIN; COMPND 13 CHAIN: H; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: HK20, HUMAN MONOCLONAL ANTIBODY LIGHT CHAIN; COMPND 16 CHAIN: L SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 3 ORGANISM_TAXID: 32630; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_VARIANT: GOLD; SOURCE 7 EXPRESSION_SYSTEM_VECTOR: PETM-13 (EMBL, HEIDELBERG); SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 TISSUE: BLOOD; SOURCE 13 CELL: MEMORY B-LYMPHOCYTE; SOURCE 14 MOL_ID: 3; SOURCE 15 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 16 ORGANISM_COMMON: HUMAN; SOURCE 17 ORGANISM_TAXID: 9606; SOURCE 18 TISSUE: BLOOD; SOURCE 19 CELL: MEMORY B-LYMPHOCYTE KEYWDS IMMUNE SYSTEM, ANTIBODY, MONOCLONAL CELLS, NEUTRALIZATION TESTS EXPDTA X-RAY DIFFRACTION AUTHOR C.SABIN,D.CORTI,V.BUZON,M.S.SEAMAN,D.LUTJE HULSIK,A.HINZ,F.VANZETTA, AUTHOR 2 G.AGATIC,C.SILACCI,J.P.M.LANGEDIJK,L.MAINETTI,G.SCARLATTI, AUTHOR 3 F.SALLUSTO,R.WEISS,A.LANZAVECCHIA,W.WEISSENHORN REVDAT 5 23-OCT-24 2XRA 1 REMARK REVDAT 4 20-DEC-23 2XRA 1 REMARK REVDAT 3 07-FEB-18 2XRA 1 SOURCE AUTHOR JRNL REVDAT 2 28-DEC-11 2XRA 1 JRNL REMARK VERSN REVDAT 1 15-DEC-10 2XRA 0 JRNL AUTH C.SABIN,D.CORTI,V.BUZON,M.S.SEAMAN,D.LUTJE HULSIK,A.HINZ, JRNL AUTH 2 F.VANZETTA,G.AGATIC,C.SILACCI,L.MAINETTI,G.SCARLATTI, JRNL AUTH 3 F.SALLUSTO,R.WEISS,A.LANZAVECCHIA,W.WEISSENHORN JRNL TITL CRYSTAL STRUCTURE AND SIZE-DEPENDENT NEUTRALIZATION JRNL TITL 2 PROPERTIES OF HK20, A HUMAN MONOCLONAL ANTIBODY BINDING TO JRNL TITL 3 THE HIGHLY CONSERVED HEPTAD REPEAT 1 OF GP41. JRNL REF PLOS PATHOG. V. 6 01195 2010 JRNL REFN ESSN 1553-7374 JRNL PMID 21124990 JRNL DOI 10.1371/JOURNAL.PPAT.1001195 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.A.LUFTIG,M.MATTU,P.DI GIOVINE,R.GELEZIUNAS,R.HRIN, REMARK 1 AUTH 2 G.BARBATO,E.BIANCHI,M.D.MILLER,A.PESSI,A.CARFI REMARK 1 TITL STRUCTURAL BASIS FOR HIV-1 NEUTRALIZATION BY A GP41 FUSION REMARK 1 TITL 2 INTERMEDIATE-DIRECTED ANTIBODY. REMARK 1 REF NAT.STRUCT.MOL.BIOL. V. 13 740 2006 REMARK 1 REFN ISSN 1545-9993 REMARK 1 PMID 16862157 REMARK 1 DOI 10.1038/NSMB1127 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.63 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 3 NUMBER OF REFLECTIONS : 28253 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.239 REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1509 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1961 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.05 REMARK 3 BIN R VALUE (WORKING SET) : 0.2840 REMARK 3 BIN FREE R VALUE SET COUNT : 96 REMARK 3 BIN FREE R VALUE : 0.3360 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4962 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 118 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.25000 REMARK 3 B22 (A**2) : 0.06000 REMARK 3 B33 (A**2) : -0.36000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.20000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.454 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.284 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.215 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.729 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.917 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.887 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5057 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6862 ; 1.183 ; 1.949 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 634 ; 5.420 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 223 ;37.443 ;25.426 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 872 ;15.175 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;15.243 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 781 ; 0.074 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3780 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3179 ; 0.622 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5131 ; 1.190 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1878 ; 1.649 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1731 ; 2.898 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. DISORDERED LOOPS REGIONS OF GP41-5HB WERE NOT MODELED. REMARK 4 REMARK 4 2XRA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-SEP-10. REMARK 100 THE DEPOSITION ID IS D_1290044580. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9765 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28254 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 37.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.3 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.35000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2CMR REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.5, 0.2 M AMMONIUM REMARK 280 SULPHATE, 25% PEG 3350 (W/V) REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.35500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, H, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 542 REMARK 465 SER A 585 REMARK 465 GLY A 586 REMARK 465 GLY A 587 REMARK 465 HIS A 1625 REMARK 465 SER A 1665 REMARK 465 ALA A 2582 REMARK 465 GLY A 3620 REMARK 465 GLY A 3621 REMARK 465 SER A 3622 REMARK 465 GLY A 3623 REMARK 465 SER A 3665 REMARK 465 GLY A 3666 REMARK 465 GLY A 3667 REMARK 465 LEU A 4583 REMARK 465 GLU A 4584 REMARK 465 GLY A 4585 REMARK 465 GLY A 4586 REMARK 465 HIS A 4587 REMARK 465 HIS A 4588 REMARK 465 HIS A 4589 REMARK 465 HIS A 4590 REMARK 465 HIS A 4591 REMARK 465 HIS A 4592 REMARK 465 GLY A 4593 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PRO H 14 O LEU H 82C 2.13 REMARK 500 O ARG L 30 O SER L 67 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER H 84 1.82 -58.68 REMARK 500 PRO H 100B 34.95 -84.50 REMARK 500 SER H 112 -77.50 -119.78 REMARK 500 SER H 113 -20.82 108.53 REMARK 500 SER H 127 125.19 113.70 REMARK 500 LYS H 129 -0.23 111.82 REMARK 500 SER H 130 17.28 -144.32 REMARK 500 ASP H 144 70.12 65.59 REMARK 500 ARG L 30 -136.00 37.24 REMARK 500 ALA L 51 -45.86 76.04 REMARK 500 SER L 67 -67.13 -129.35 REMARK 500 ASN L 138 72.91 48.00 REMARK 500 ASN L 152 28.70 32.58 REMARK 500 ASN L 158 55.03 -151.68 REMARK 500 SER L 182 160.91 113.79 REMARK 500 ARG L 211 168.01 157.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1DF4 RELATED DB: PDB REMARK 900 INTERACTIONS BETWEEN HIV-1 GP41 CORE AND DETERGENTS AND THEIR REMARK 900 IMPLICATIONS FOR MEMBRANE FUSION REMARK 900 RELATED ID: 1DF5 RELATED DB: PDB REMARK 900 INTERACTIONS BETWEEN HIV-1 GP41 CORE AND DETERGENTS AND THEIR REMARK 900 IMPLICATIONS FOR MEMBRANE FUSION REMARK 900 RELATED ID: 1DLB RELATED DB: PDB REMARK 900 HELICAL INTERACTIONS IN THE HIV-1 GP41 CORE REVEALS STRUCTURAL REMARK 900 BASIS FOR THE INHIBITORY ACTIVITY OF GP41 PEPTIDES REMARK 900 RELATED ID: 1OPN RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF CCR5 RECEPTOR IN COMPLEX WITH HIVGP120 REMARK 900 ENVELOPE GLYCOPROTEIN AND CD4 RECEPTOR REMARK 900 RELATED ID: 1OPW RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF CCR5 RECEPTOR IN COMPLEX WITH HIVGP120 REMARK 900 ENVELOPE GLYCOPROTEIN AND CD4 RECEPTOR REMARK 900 RELATED ID: 1GC1 RELATED DB: PDB REMARK 900 HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN REMARK 900 ANTIBODY REMARK 900 RELATED ID: 1OPT RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF CCR5 RECEPTOR IN COMPLEX WITH HIVGP120 REMARK 900 ENVELOPE GLYCOPROTEIN AND CD4 RECEPTOR REMARK 900 RELATED ID: 1K33 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE GP41 CORE MUTANT REMARK 900 RELATED ID: 1RZJ RELATED DB: PDB REMARK 900 HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4AND REMARK 900 INDUCED NEUTRALIZING ANTIBODY 17B REMARK 900 RELATED ID: 1G9M RELATED DB: PDB REMARK 900 HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4AND REMARK 900 INDUCED NEUTRALIZING ANTIBODY 17B REMARK 900 RELATED ID: 1K34 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF GP41 CORE MUTANT REMARK 900 RELATED ID: 1AIK RELATED DB: PDB REMARK 900 HIV GP41 CORE STRUCTURE REMARK 900 RELATED ID: 2CMR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY D5 FAB BOUND REMARK 900 TO THE GP41 INNER -CORE MIMETIC 5-HELIX REMARK 900 RELATED ID: 1GZL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF C14LINKMID/IQN17: A CROSS-LINKED INHIBITOR OF REMARK 900 HIV-1 ENTRY BOUND TO THE GP41 HYDROPHOBIC POCKET REMARK 900 RELATED ID: 1MZI RELATED DB: PDB REMARK 900 SOLUTION ENSEMBLE STRUCTURES OF HIV-1 GP41 2F5 MAB EPITOPE DBREF 2XRA A 543 582 UNP P04578 ENV_HVIH2 543 582 DBREF 2XRA A 1625 1662 UNP P04578 ENV_HVIH2 625 662 DBREF 2XRA A 2543 2582 UNP P04578 ENV_HVIH2 543 582 DBREF 2XRA A 3625 3662 UNP P04578 ENV_HVIH2 625 662 DBREF 2XRA A 4543 4582 UNP P04578 ENV_HVIH2 543 582 DBREF 2XRA H 3 216 PDB 2XRA 2XRA 3 216 DBREF 2XRA L 1 214 PDB 2XRA 2XRA 1 214 SEQADV 2XRA MET A 542 UNP P04578 EXPRESSION TAG SEQADV 2XRA GLY A 583 UNP P04578 INSERTION SEQADV 2XRA GLY A 584 UNP P04578 INSERTION SEQADV 2XRA SER A 585 UNP P04578 INSERTION SEQADV 2XRA GLY A 586 UNP P04578 INSERTION SEQADV 2XRA GLY A 587 UNP P04578 INSERTION SEQADV 2XRA GLY A 1663 UNP P04578 INSERTION SEQADV 2XRA SER A 1664 UNP P04578 INSERTION SEQADV 2XRA SER A 1665 UNP P04578 INSERTION SEQADV 2XRA GLY A 2541 UNP P04578 INSERTION SEQADV 2XRA GLY A 2542 UNP P04578 INSERTION SEQADV 2XRA GLY A 3620 UNP P04578 INSERTION SEQADV 2XRA GLY A 3621 UNP P04578 INSERTION SEQADV 2XRA SER A 3622 UNP P04578 INSERTION SEQADV 2XRA GLY A 3623 UNP P04578 INSERTION SEQADV 2XRA GLY A 3624 UNP P04578 INSERTION SEQADV 2XRA GLY A 3663 UNP P04578 INSERTION SEQADV 2XRA SER A 3664 UNP P04578 INSERTION SEQADV 2XRA SER A 3665 UNP P04578 INSERTION SEQADV 2XRA GLY A 3666 UNP P04578 INSERTION SEQADV 2XRA GLY A 3667 UNP P04578 INSERTION SEQADV 2XRA LEU A 4583 UNP P04578 EXPRESSION TAG SEQADV 2XRA GLU A 4584 UNP P04578 EXPRESSION TAG SEQADV 2XRA GLY A 4585 UNP P04578 EXPRESSION TAG SEQADV 2XRA GLY A 4586 UNP P04578 EXPRESSION TAG SEQADV 2XRA HIS A 4587 UNP P04578 EXPRESSION TAG SEQADV 2XRA HIS A 4588 UNP P04578 EXPRESSION TAG SEQADV 2XRA HIS A 4589 UNP P04578 EXPRESSION TAG SEQADV 2XRA HIS A 4590 UNP P04578 EXPRESSION TAG SEQADV 2XRA HIS A 4591 UNP P04578 EXPRESSION TAG SEQADV 2XRA HIS A 4592 UNP P04578 EXPRESSION TAG SEQADV 2XRA GLY A 4593 UNP P04578 EXPRESSION TAG SEQRES 1 A 228 MET GLN LEU LEU SER GLY ILE VAL GLN GLN GLN ASN ASN SEQRES 2 A 228 LEU LEU ARG ALA ILE GLU ALA GLN GLN HIS LEU LEU GLN SEQRES 3 A 228 LEU THR VAL TRP GLY ILE LYS GLN LEU GLN ALA ARG ILE SEQRES 4 A 228 LEU ALA GLY GLY SER GLY GLY HIS THR THR TRP MET GLU SEQRES 5 A 228 TRP ASP ARG GLU ILE ASN ASN TYR THR SER LEU ILE HIS SEQRES 6 A 228 SER LEU ILE GLU GLU SER GLN ASN GLN GLN GLU LYS ASN SEQRES 7 A 228 GLU GLN GLU LEU LEU GLU GLY SER SER GLY GLY GLN LEU SEQRES 8 A 228 LEU SER GLY ILE VAL GLN GLN GLN ASN ASN LEU LEU ARG SEQRES 9 A 228 ALA ILE GLU ALA GLN GLN HIS LEU LEU GLN LEU THR VAL SEQRES 10 A 228 TRP GLY ILE LYS GLN LEU GLN ALA ARG ILE LEU ALA GLY SEQRES 11 A 228 GLY SER GLY GLY HIS THR THR TRP MET GLU TRP ASP ARG SEQRES 12 A 228 GLU ILE ASN ASN TYR THR SER LEU ILE HIS SER LEU ILE SEQRES 13 A 228 GLU GLU SER GLN ASN GLN GLN GLU LYS ASN GLU GLN GLU SEQRES 14 A 228 LEU LEU GLU GLY SER SER GLY GLY GLN LEU LEU SER GLY SEQRES 15 A 228 ILE VAL GLN GLN GLN ASN ASN LEU LEU ARG ALA ILE GLU SEQRES 16 A 228 ALA GLN GLN HIS LEU LEU GLN LEU THR VAL TRP GLY ILE SEQRES 17 A 228 LYS GLN LEU GLN ALA ARG ILE LEU ALA LEU GLU GLY GLY SEQRES 18 A 228 HIS HIS HIS HIS HIS HIS GLY SEQRES 1 H 223 GLN LEU VAL GLU SER GLY ALA GLU VAL LYS LYS PRO GLY SEQRES 2 H 223 SER SER VAL LYS VAL SER CYS LYS THR SER GLY GLY THR SEQRES 3 H 223 PHE ASN ARG LEU ALA MET SER TRP VAL ARG GLN ALA PRO SEQRES 4 H 223 GLY GLN GLY LEU GLU TRP MET GLY GLY ILE MET PRO ILE SEQRES 5 H 223 PHE ASP ILE THR ASN TYR ALA GLN LYS PHE GLN GLY ARG SEQRES 6 H 223 VAL THR ILE ILE THR ASP GLU SER THR SER THR ALA TYR SEQRES 7 H 223 MET GLU LEU ARG SER LEU THR SER GLU ASP SER ALA VAL SEQRES 8 H 223 TYR TYR CYS ALA ARG ALA SER TYR SER SER SER SER PRO SEQRES 9 H 223 TYR ALA PHE ASP ILE TRP GLY GLN GLY THR MET VAL THR SEQRES 10 H 223 VAL SER SER ALA SER THR LYS GLY PRO SER VAL PHE PRO SEQRES 11 H 223 LEU ALA PRO SER SER LYS SER THR SER GLY GLY THR ALA SEQRES 12 H 223 ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO SEQRES 13 H 223 VAL THR VAL SER TRP ASN SER GLY ALA LEU THR SER GLY SEQRES 14 H 223 VAL HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU SEQRES 15 H 223 TYR SER LEU SER SER VAL VAL THR VAL PRO SER SER SER SEQRES 16 H 223 LEU GLY THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS SEQRES 17 H 223 PRO SER ASN THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SEQRES 18 H 223 SER CYS SEQRES 1 L 215 ASP ILE GLN MET THR GLN SER PRO SER SER LEU SER PRO SEQRES 2 L 215 SER VAL GLY ASP ARG VAL THR ILE THR CYS GLN ALA SER SEQRES 3 L 215 GLN ASP ILE ARG ASN HIS LEU ASN TRP TYR GLN GLN LYS SEQRES 4 L 215 PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR ASP ALA SER SEQRES 5 L 215 ASN LEU ALA THR GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 L 215 GLY SER GLY THR ASP PHE THR PHE THR ILE SER SER LEU SEQRES 7 L 215 GLN PRO GLU ASP LEU ALA THR TYR TYR CYS GLN HIS TYR SEQRES 8 L 215 ASP ASP LEU PRO ARG ILE THR PHE GLY GLN GLY THR ARG SEQRES 9 L 215 LEU GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE SEQRES 10 L 215 ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR SEQRES 11 L 215 ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG SEQRES 12 L 215 GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SEQRES 13 L 215 SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER SEQRES 14 L 215 LYS ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SEQRES 15 L 215 SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS SEQRES 16 L 215 GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SEQRES 17 L 215 SER PHE ASN ARG GLY GLY CYS FORMUL 4 HOH *118(H2 O) HELIX 1 1 GLN A 543 ALA A 582 1 40 HELIX 2 2 THR A 1627 GLU A 1662 1 36 HELIX 3 3 GLY A 2542 LEU A 2581 1 40 HELIX 4 4 GLY A 3624 LEU A 3661 1 38 HELIX 5 5 GLN A 4543 LEU A 4581 1 39 HELIX 6 6 THR H 28 LEU H 32 5 5 HELIX 7 7 PRO H 52A ASP H 55 5 4 HELIX 8 8 GLU H 73 THR H 75 5 3 HELIX 9 9 SER H 156 ALA H 158 5 3 HELIX 10 10 LYS H 201 ASN H 204 5 4 HELIX 11 11 GLN L 79 LEU L 83 5 5 HELIX 12 12 SER L 121 SER L 127 1 7 HELIX 13 13 SER L 182 GLU L 187 1 6 SHEET 1 HA 4 LEU H 4 GLU H 6 0 SHEET 2 HA 4 VAL H 18 THR H 24 -1 O LYS H 23 N VAL H 5 SHEET 3 HA 4 THR H 77 LEU H 82 -1 O ALA H 78 N CYS H 22 SHEET 4 HA 4 VAL H 67 ASP H 72 -1 O THR H 68 N GLU H 81 SHEET 1 HB 4 GLU H 10 LYS H 12 0 SHEET 2 HB 4 THR H 107 VAL H 111 1 O MET H 108 N GLU H 10 SHEET 3 HB 4 ALA H 88 ALA H 95 -1 O ALA H 88 N VAL H 109 SHEET 4 HB 4 PHE H 100E TRP H 103 -1 N ASP H 101 O ARG H 94 SHEET 1 HC 6 GLU H 10 LYS H 12 0 SHEET 2 HC 6 THR H 107 VAL H 111 1 O MET H 108 N GLU H 10 SHEET 3 HC 6 ALA H 88 ALA H 95 -1 O ALA H 88 N VAL H 109 SHEET 4 HC 6 MET H 34 GLN H 39 -1 O SER H 35 N ALA H 93 SHEET 5 HC 6 LEU H 45 MET H 52 -1 O GLU H 46 N ARG H 38 SHEET 6 HC 6 ILE H 56 TYR H 59 -1 O ILE H 56 N MET H 52 SHEET 1 HD 2 PHE H 100E TRP H 103 0 SHEET 2 HD 2 ALA H 88 ALA H 95 -1 O ARG H 94 N ASP H 101 SHEET 1 HE 4 SER H 120 LEU H 124 0 SHEET 2 HE 4 THR H 135 TYR H 145 -1 O GLY H 139 N LEU H 124 SHEET 3 HE 4 TYR H 176 PRO H 185 -1 O TYR H 176 N TYR H 145 SHEET 4 HE 4 VAL H 169 LEU H 170 1 O VAL H 169 N SER H 177 SHEET 1 HF 4 SER H 120 LEU H 124 0 SHEET 2 HF 4 THR H 135 TYR H 145 -1 O GLY H 139 N LEU H 124 SHEET 3 HF 4 TYR H 176 PRO H 185 -1 O TYR H 176 N TYR H 145 SHEET 4 HF 4 VAL H 163 THR H 165 -1 O HIS H 164 N VAL H 181 SHEET 1 HG 2 VAL H 169 LEU H 170 0 SHEET 2 HG 2 TYR H 176 PRO H 185 1 O SER H 177 N VAL H 169 SHEET 1 HH 3 THR H 151 TRP H 154 0 SHEET 2 HH 3 TYR H 194 HIS H 200 -1 O ASN H 197 N SER H 153 SHEET 3 HH 3 THR H 205 VAL H 211 -1 O THR H 205 N HIS H 200 SHEET 1 LA 4 MET L 4 SER L 7 0 SHEET 2 LA 4 VAL L 19 ALA L 25 -1 O THR L 22 N SER L 7 SHEET 3 LA 4 ASP L 70 ILE L 75 -1 O PHE L 71 N CYS L 23 SHEET 4 LA 4 PHE L 62 GLY L 66 -1 O SER L 63 N THR L 74 SHEET 1 LB 4 SER L 10 LEU L 11 0 SHEET 2 LB 4 THR L 102 LEU L 104 -1 O ARG L 103 N LEU L 11 SHEET 3 LB 4 THR L 85 ASP L 92 -1 O TYR L 86 N THR L 102 SHEET 4 LB 4 ARG L 95A PHE L 98 -1 O ARG L 95A N ASP L 92 SHEET 1 LC 6 SER L 10 LEU L 11 0 SHEET 2 LC 6 THR L 102 LEU L 104 -1 O ARG L 103 N LEU L 11 SHEET 3 LC 6 THR L 85 ASP L 92 -1 O TYR L 86 N THR L 102 SHEET 4 LC 6 LEU L 33 GLN L 38 -1 O ASN L 34 N GLN L 89 SHEET 5 LC 6 LYS L 45 TYR L 49 -1 O LYS L 45 N GLN L 37 SHEET 6 LC 6 ASN L 53 LEU L 54 -1 O ASN L 53 N TYR L 49 SHEET 1 LD 2 ARG L 95A PHE L 98 0 SHEET 2 LD 2 THR L 85 ASP L 92 -1 O HIS L 90 N THR L 97 SHEET 1 LE 4 SER L 114 PHE L 118 0 SHEET 2 LE 4 SER L 131 PHE L 139 -1 O VAL L 133 N PHE L 118 SHEET 3 LE 4 TYR L 173 THR L 180 -1 O TYR L 173 N PHE L 139 SHEET 4 LE 4 SER L 159 VAL L 163 -1 O GLN L 160 N THR L 178 SHEET 1 LF 4 LEU L 154 GLN L 155 0 SHEET 2 LF 4 ALA L 144 VAL L 150 -1 O VAL L 150 N LEU L 154 SHEET 3 LF 4 VAL L 191 HIS L 198 -1 O ALA L 193 N LYS L 149 SHEET 4 LF 4 VAL L 205 ASN L 210 -1 O VAL L 205 N VAL L 196 SSBOND 1 CYS H 22 CYS H 92 1555 1555 2.04 SSBOND 2 CYS H 140 CYS H 196 1555 1555 2.04 SSBOND 3 CYS L 23 CYS L 88 1555 1555 2.01 SSBOND 4 CYS L 134 CYS L 194 1555 1555 2.03 CISPEP 1 ALA A 582 GLY A 583 0 -6.31 CISPEP 2 GLY A 583 GLY A 584 0 -3.04 CISPEP 3 PRO H 41 GLY H 42 0 2.24 CISPEP 4 GLY H 42 GLN H 43 0 -9.39 CISPEP 5 PRO H 126 SER H 127 0 -0.75 CISPEP 6 SER H 128 LYS H 129 0 7.37 CISPEP 7 SER H 132 GLY H 133 0 -3.55 CISPEP 8 GLY H 133 GLY H 134 0 -7.53 CISPEP 9 PHE H 146 PRO H 147 0 -3.91 CISPEP 10 GLU H 148 PRO H 149 0 0.75 CISPEP 11 ASP L 1 ILE L 2 0 -1.06 CISPEP 12 SER L 7 PRO L 8 0 -4.99 CISPEP 13 LEU L 94 PRO L 95 0 2.59 CISPEP 14 TYR L 140 PRO L 141 0 0.16 CISPEP 15 ARG L 211 GLY L 212 0 2.64 CRYST1 75.947 62.710 76.610 90.00 97.70 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013167 0.000000 0.001780 0.00000 SCALE2 0.000000 0.015946 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013172 0.00000